Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial

Research output: Contribution to journalJournal articleResearchpeer-review

Rikke Søgaard, Barbara Malene B Fischer, Jann Mortensen, Liselotte Højgaard, Ulrik Lassen

Positron emission tomography (PET)/CT has become a widely used technology for preoperative staging of non-small cell lung cancer (NSCLC). Two recent randomized controlled trials (RCT) have established its efficacy over conventional staging, but no studies have assessed its cost-effectiveness. The objective of this study was to assess the cost-effectiveness of PET/CT as an adjunct to conventional workup for preoperative staging of NSCLC.
Original languageEnglish
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume38
Issue number5
Pages (from-to)802-9
Number of pages8
ISSN1619-7070
DOIs
Publication statusPublished - 2011

ID: 40161630